Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples